Roelants Fabienne, Lavand'homme Patricia
From the Department of Anesthesiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Eur J Anaesthesiol. 2015 Nov;32(11):805-11. doi: 10.1097/EJA.0000000000000347.
Adjuvants to local anaesthetics for epidural labour analgesia are useful if they reduce side-effects or personnel requirements. Epidural clonidine improves analgesia and provides a significant local anaesthetic-sparing effect.
To compare the number of rescue doses administered by the anaesthesiologist when clonidine or sufentanil is added to epidural ropivacaine.
A randomised double-blind trial.
Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium, from June 2009 to June 2010.
One hundred and ninety-five women in labour.
Epidural analgesia initiated with 10 ml ropivacaine 0.1%, women randomised to receive patient-controlled epidural analgesia (5 ml demand bolus, 15 min lockout) with ropivacaine 0.1% and sufentanil 0.25 μg ml⁻¹ (RS group; n = 65), or ropivacaine 0.1% and clonidine 1.5 μg ml⁻¹ (RC1.5 group; n = 65) or ropivacaine 0.1% and clonidine 3 μg ml⁻¹ (RC3 group; n = 65). Rescue analgesia was available as needed – 10 ml ropivacaine 0.1% (numerical rating scale <6/10) or ropivacaine 0.2% (numerical rating scale ≥6/10).
Comparison of the total number of rescue doses.
The total number of rescue doses was similar among the groups [median (interquartile range): 1 (0 to 1) in the RC1.5 group, 1 (1 to 2) in the RC3 group and 2 (1 to 2) in the RS group; overall P = 0.056]. However, fewer patients in both the RC1.5 and RC3 groups needed two or more rescue doses (25 and 29% versus 52% in the RS group, P = 0.01). The rate of instrumental delivery was higher in both clonidine groups (13 and 12% versus 0%, P = 0.03). Nausea was significantly less frequent in both the clonidine groups. Satisfaction scores, total ropivacaine consumption, maternal sedation, and hypotension and neonatal outcomes were similar among the groups.
Compared with sufentanil 0.25 μg ml⁻¹, addition of clonidine (1.5 to 3 μg ml⁻¹) to patient-controlled epidural analgesia with ropivacaine 0.1% provided similar labour analgesia and a similar need for anaesthesiologist-administered rescue doses. Clonidine 3 μg ml⁻¹ did not offer any advantage over clonidine 1.5 μg ml⁻¹. The instrumentation rate was higher in both the clonidine groups.
用于硬膜外分娩镇痛的局部麻醉辅助药若能减少副作用或人员需求则很有用。硬膜外可乐定可改善镇痛效果并产生显著的局部麻醉药节省效应。
比较在硬膜外罗哌卡因中添加可乐定或舒芬太尼时麻醉医生给予的补救剂量数量。
一项随机双盲试验。
2009年6月至2010年6月,比利时布鲁塞尔天主教鲁汶大学圣吕克大学医院。
195名分娩妇女。
以10毫升0.1%罗哌卡因开始硬膜外镇痛,随机分组的妇女接受患者自控硬膜外镇痛(5毫升按需推注量,15分钟锁定时间),分别使用0.1%罗哌卡因和0.25微克/毫升舒芬太尼(RS组;n = 65),或0.1%罗哌卡因和1.5微克/毫升可乐定(RC1.5组;n = 65),或0.1%罗哌卡因和3微克/毫升可乐定(RC3组;n = 65)。根据需要提供补救镇痛——10毫升0.1%罗哌卡因(数字评分量表<6/10)或0.2%罗哌卡因(数字评分量表≥6/10)。
比较补救剂量总数。
各组补救剂量总数相似[中位数(四分位间距):RC1.5组为1(0至1),RC3组为1(1至2),RS组为2(1至2);总体P = 0.056]。然而,RC1.5组和RC3组中需要两次或更多次补救剂量的患者较少(分别为25%和29%,而RS组为52%,P = 0.01)。两个可乐定组的器械助产率较高(分别为13%和12%,而RS组为0%,P = 0.03)。两个可乐定组恶心的发生率显著较低。各组的满意度评分、罗哌卡因总消耗量、产妇镇静情况、低血压及新生儿结局相似。
与0.25微克/毫升舒芬太尼相比,在0.1%罗哌卡因患者自控硬膜外镇痛中添加可乐定(1.5至3微克/毫升)可提供相似的分娩镇痛效果,且对麻醉医生给予补救剂量的需求相似。3微克/毫升可乐定并不比1.5微克/毫升可乐定有任何优势。两个可乐定组的器械助产率较高。